Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Geoff Eich Amgen, Inc., Thousand Oaks, California, USA. e-mail: geich@amgen.com 1. Anonymous. Nat. Biotechnol. 31, 1055 (2013). 2. World Health Organization. 55th Consultation on International Nonproprietary Names for Pharmaceutical Substances (Geneva, 16–18 October 2012) http://www.who....
Amgen USA Inc., and/or its affiliates (collectively, “Amgen”) offers you access to the websites, applications and digital services on or to which these Terms are linked or referenced (collectively, the “Services”).
美国 中文 English 2024-08更新 企业注册号: 0063260 成立日期: 1992-07-17 企查查编码: QUSQP83G0R 办公地址: ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320, USA 基本信息 企业注册号 0063260 企业名称 AMGEN INC. 企业状态 ACTIVE 成立日期 ...
Assignee: AMGEN INC. (Thousand Oaks, CA, US) International Classes: C07K16/22; A61K39/395; A61K45/06; A61K47/60; C07K14/51; C07K14/76; C07K14/79; C07K16/18; C12N15/63; A61K39/00 View Patent Images: Download PDF 11939372 US Patent References: 11466079 N/A 2022-10-11 ...
AMGEN INC. (Thousand Oaks CA) and Belgium-based UCB SA said that their osteoporosis drug met all the primary endpoints by reducing the incidence of new vertebral fracture in postmenopausal women with osteoporosis in a late-stage study.The article reports that according to a study, the drug Rom...
Amgen Inc. (Thousand Oaks, CA, US) Primary Class: 546/256 International Classes: C07D401/14 Field of Search: 546/256, 514/333 View Patent Images: Download PDF 7989631 US Patent References: 6995162Substituted alkylamine derivatives and methods of useFebruary, 2006Chen et al. ...
AMGEN INC. (Thousand Oaks, CALIFORNIA, US) Claims: What is claimed: 1.A method for inhibiting activation of human PAC1 receptor in a patient having a headache condition comprising administering to the patient an effective amount of a monoclonal antibody or binding fragment thereof, wherein the ...
(obtained from C. F. Morris, Amgen Inc., Thousand Oaks, Calif.) were transformed with the ligation mixture and plated in L-broth agar with kanamycin. Colonies were selected and both replica-plated and miniprepped by the alkaline method (Maniatis et al., supra). Miniprepped DNA samples ...
Assignee: Amgen Inc. (Thousand Oaks, CA, US) Primary Class: 548/469 Other Classes: 548/444, 548/503, 548/509 International Classes: C07D209/82; A61K31/403; C07D249/18; A61K31/404; A61K31/4045; A61K31/407; A61K31/4178; A61K31/4184; A61K31/4192; A61K31/422; A61K31/437...